Genesis HealthCare (GEN) Tops Q4 EPS by 2c; offers guidance

Genesis HealthCare (NASDAQ: GEN) reported Q4 EPS of $0.67, $0.02 better than the analyst estimate of $0.65. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.24 billion.

GUIDANCE:

Genesis HealthCare sees Q1 2027 EPS of $0.68-$0.70, versus the consensus of $0.68. Genesis HealthCare sees Q1 2027 revenue of $1.3-1.325 billion, versus the consensus of $1.272 billion.

Genesis HealthCare sees FY2027 EPS of $2.85-$2.95, versus the consensus of $2.55. Genesis HealthCare sees FY2027 revenue of $5.325-5.425 billion, versus the consensus of $4.964 billion.

For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AeroVironment restates quarterly financials, citing $89M goodwill error